IFM Investors Pty Ltd Purchases 4,224 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

IFM Investors Pty Ltd boosted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 10.8% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,162 shares of the medical device company's stock after purchasing an additional 4,224 shares during the quarter. IFM Investors Pty Ltd's holdings in Cooper Companies were worth $3,641,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also bought and sold shares of the company. OFI Invest Asset Management bought a new position in shares of Cooper Companies during the 4th quarter valued at $34,000. City Holding Co. bought a new position in shares of Cooper Companies during the 1st quarter valued at $34,000. New Age Alpha Advisors LLC bought a new position in shares of Cooper Companies during the 4th quarter valued at $38,000. Covestor Ltd grew its holdings in shares of Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock valued at $42,000 after purchasing an additional 120 shares during the last quarter. Finally, Atala Financial Inc bought a new position in shares of Cooper Companies during the 4th quarter valued at $51,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently commented on the stock. Loop Capital set a $100.00 target price on shares of Cooper Companies in a report on Tuesday, June 17th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research note on Thursday, March 13th. Needham & Company LLC upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 price objective on the stock in a report on Tuesday, June 17th. Wells Fargo & Company dropped their target price on shares of Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research note on Friday, May 30th. Finally, Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Three investment analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $99.70.

Cooper Companies Price Performance

Shares of COO stock traded up $0.69 on Wednesday, hitting $74.95. 3,548,980 shares of the stock traded hands, compared to its average volume of 1,735,400. The firm has a market cap of $14.99 billion, a price-to-earnings ratio of 36.38, a PEG ratio of 1.81 and a beta of 0.99. The firm has a 50 day simple moving average of $75.16 and a two-hundred day simple moving average of $82.95. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The company had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same period last year, the company posted $0.85 earnings per share. Cooper Companies's quarterly revenue was up 6.3% on a year-over-year basis. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.